Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone in Children and Adolescents with Bipolar I Depression
NCT02046369Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Mar 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Lurasidone with Placebo (2 arms). Primary endpoint: Children's Depression Rating Scale, Revised Total Score at 6 weeks. Started Mar 2014; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT02046369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046369.